Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Torisu

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|October 1, 1988
[Recent progress on clinical immunology. 1. Eosinophils]M Torisu
Seikeigeka. Orthopedic Surgery|April 1, 1970
[Problems of the ASLO value in orthopedic diagnosis]H Sonozaki, M Torisu
Annals of the Rheumatic Diseases|March 1, 1970
Complement system in synovial fluids from patients with rheumatoid arthritisH Sonozaki, M Torisu
Surgery|March 1, 1983
New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destructionM Katano, M Torisu
Clinical Immunology and Immunopathology|June 1, 1982
Anisakis and eosinophil. II. Eosinophilic phlegmon experimentally induced in normal rabbits by parasite-derived eosinophil chemotactic factor (ECF-P)K Iwasaki, M Torisu
Cancer|July 1, 1982
Neutrophil-mediated tumor cell destruction in cancer ascitesM Katano, M Torisu
Journal of Experimental Pathology|January 1, 1989
Potential role of Kupffer cells in initiating liver injury during endotoxemiaM Katoh, M Torisu
Surgery|May 1, 1989
Immunologic studies on myasthenia gravis. II: A new chemotactic factor for lymphocytes found in patients with myasthenia gravisT Annoh, M Torisu
Clinical Immunology and Immunopathology|May 1, 1987
Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5T Fujimura, M Torisu
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 1, 1975
[Prevention of the posttransfusion hepatitis by a specific immunoglobulin (author's transl)]M Torisu, J Tanaka
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|October 1, 1988
[Recent progress on clinical immunology. 1. Eosinophils]M Torisu
Seikeigeka. Orthopedic Surgery|April 1, 1970
[Problems of the ASLO value in orthopedic diagnosis]H Sonozaki, M Torisu
Annals of the Rheumatic Diseases|March 1, 1970
Complement system in synovial fluids from patients with rheumatoid arthritisH Sonozaki, M Torisu
Surgery|March 1, 1983
New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destructionM Katano, M Torisu
Clinical Immunology and Immunopathology|June 1, 1982
Anisakis and eosinophil. II. Eosinophilic phlegmon experimentally induced in normal rabbits by parasite-derived eosinophil chemotactic factor (ECF-P)K Iwasaki, M Torisu
Cancer|July 1, 1982
Neutrophil-mediated tumor cell destruction in cancer ascitesM Katano, M Torisu
Journal of Experimental Pathology|January 1, 1989
Potential role of Kupffer cells in initiating liver injury during endotoxemiaM Katoh, M Torisu
Surgery|May 1, 1989
Immunologic studies on myasthenia gravis. II: A new chemotactic factor for lymphocytes found in patients with myasthenia gravisT Annoh, M Torisu
Clinical Immunology and Immunopathology|May 1, 1987
Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5T Fujimura, M Torisu
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 1, 1975
[Prevention of the posttransfusion hepatitis by a specific immunoglobulin (author's transl)]M Torisu, J Tanaka
Pageof 13